Aronora

Privately held: no public share price

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
AB002No recent activity
Phase 2
Protein CProtein / enzyme therapeutic
Chronic Kidney Disease
Phase 2
Factor XIMonoclonal antibody
Chronic Kidney Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.